Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verheij

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
Physics and Imaging in Radiation Oncology|January 18, 2021
Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumoursMarie Lambrecht, Jan-Jakob Sonke, Ursula Nestle, et al.
Molecular Imaging and Biology|September 17, 2009
Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancerTzu-I J Yang, Tjeerd S Aukema, Harm van Tinteren, et al.
Biochemical Pharmacology|September 7, 2007
Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cellsStefan R Vink, Arnold H van der Luit, Jeffrey B Klarenbeek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 2, 2020
The use of real-world evidence to audit normal tissue complication probability models for acute esophageal toxicity in non-small cell lung cancer patientsMargriet H Kwint, Iris Walraven, Marcel Verheij, et al.
Nanoscale|August 12, 2020
Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticlesSara Zalba, Ann L B Seynhaeve, Jos F Brouwers, et al.
Blood|March 14, 2014
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivityRogier W Rooswinkel, Bert van de Kooij, Evert de Vries, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2014
IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancerAnouk Kirsten Trip, Jasper Nijkamp, Harm van Tinteren, et al.
Radiation Oncology (London, England)|January 22, 2016
Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspectiveMarie Lambrecht, Christos Melidis, Jan-Jakob Sonke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Combining radiotherapy with APO010 in cancer treatmentInge Verbrugge, Esther H J Wissink, Rogier W Rooswinkel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 29, 2004
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment responseMarina Kartachova, Rick L M Haas, Renato A Valdés Olmos, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Physics and Imaging in Radiation Oncology|January 18, 2021
Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumoursMarie Lambrecht, Jan-Jakob Sonke, Ursula Nestle, et al.
Molecular Imaging and Biology|September 17, 2009
Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancerTzu-I J Yang, Tjeerd S Aukema, Harm van Tinteren, et al.
Biochemical Pharmacology|September 7, 2007
Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cellsStefan R Vink, Arnold H van der Luit, Jeffrey B Klarenbeek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 2, 2020
The use of real-world evidence to audit normal tissue complication probability models for acute esophageal toxicity in non-small cell lung cancer patientsMargriet H Kwint, Iris Walraven, Marcel Verheij, et al.
Nanoscale|August 12, 2020
Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticlesSara Zalba, Ann L B Seynhaeve, Jos F Brouwers, et al.
Blood|March 14, 2014
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivityRogier W Rooswinkel, Bert van de Kooij, Evert de Vries, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2014
IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancerAnouk Kirsten Trip, Jasper Nijkamp, Harm van Tinteren, et al.
Radiation Oncology (London, England)|January 22, 2016
Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspectiveMarie Lambrecht, Christos Melidis, Jan-Jakob Sonke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Combining radiotherapy with APO010 in cancer treatmentInge Verbrugge, Esther H J Wissink, Rogier W Rooswinkel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 29, 2004
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment responseMarina Kartachova, Rick L M Haas, Renato A Valdés Olmos, et al.
Pageof 19